scinapse is loading now...
Eleftherios P. Diamandis
University of Toronto
1,108Publications
97H-index
39.2kCitations
Publications 1108
Newest
Published on Mar 1, 2019in Critical Reviews in Clinical Laboratory Sciences 6.48
Stella K. Vasiliou2
Estimated H-index: 2
(University of Toronto),
Eleftherios P. Diamandis97
Estimated H-index: 97
(University of Toronto)
AbstractBreast cancer (BCa) is the second most common cancer worldwide and the most prevalent cancer in women. The majority of BCa cases are positive (+) for the estrogen receptor (ER+, 80%) and progesterone receptor (PR+, 65%). Estrogen and progesterone hormones are known to be involved in cancer progression, and thus hormonal deprivation is used as an effective treatment for ER+PR+ BCa subtypes. However, some ER+PR+ BCa patients develop resistance to such therapies. Meanwhile, chemotherapy is ...
Source Cite
Published on Jan 18, 2019in BMC Medicine 9.09
Clare Fiala3
Estimated H-index: 3
(Mount Sinai Hospital),
Eleftherios P. Diamandis97
Estimated H-index: 97
Where should I submit my paper? This is a question that young scientists and trainees frequently ask. In this Commentary, we advise on how to make such a decision whilst balancing the risks and benefits. We argue that trying to publish in top tier journals may not always be the best option and that publishing in indexed, open access journals may expose research to the same or larger audiences. The value of research should not be judged according to the publishing journal’s name, but rather from ...
Source Cite
Published on Jan 1, 2019in Clinical Biochemistry 2.58
Lampros Dimitrakopoulos2
Estimated H-index: 2
,
Ioannis Prassas13
Estimated H-index: 13
+ 3 AuthorsGeorge S. Charames2
Estimated H-index: 2
Source Cite
Published on Mar 26, 2019in Clinical Chemistry and Laboratory Medicine 3.56
Clare Fiala3
Estimated H-index: 3
,
Jennifer Taher , Eleftherios P. Diamandis97
Estimated H-index: 97
Source Cite
Published on Mar 1, 2019
Source Cite
Published on Oct 3, 2018in Critical Reviews in Clinical Laboratory Sciences 6.48
Milena Music (University of Toronto), Ioannis Prassas13
Estimated H-index: 13
(Mount Sinai Hospital, Toronto),
Eleftherios P. Diamandis97
Estimated H-index: 97
AbstractCancer immunotherapy, a treatment that selectively augments a patient’s anti-tumor immune response, is a breakthrough advancement in personalized medicine. A subset of cancer patients undergoing immunotherapy have displayed robust and long-lasting therapeutic responses. Currently, the spotlight is on the use of blocking antibodies against the T-cell checkpoint molecules, cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programed cell death-1 (PD-1)/programed death-ligand 1 (PD-L1...
Source Cite
Published on Feb 8, 2018in Nature Reviews Rheumatology 15.66
Katerina Oikonomopoulou19
Estimated H-index: 19
,
Eleftherios P. Diamandis97
Estimated H-index: 97
+ 1 AuthorsVinod Chandran34
Estimated H-index: 34
Proteinases orchestrate many processes in inflammatory arthritis, but their ability to signal via proteolytically activated receptors is often overlooked. This Review provides an overview of proteinases and their receptors in inflammatory arthritis, alongside suggestions for therapeutically targeting these pathways.
4 Citations Source Cite
Published on Feb 14, 2018in F1000Research
Felix Leung9
Estimated H-index: 9
(University of Toronto),
Marcus Q. Bernardini19
Estimated H-index: 19
(University of Toronto)
+ 4 AuthorsVathany Kulasingam19
Estimated H-index: 19
(University of Toronto)
Background: To elucidate potential markers of endometriosis and endometriosis-associated endometrioid and clear cell ovarian carcinomas using mass spectrometry-based proteomics. Methods: A total of 21 fresh, frozen tissues from patients diagnosed with clear cell carcinoma, endometrioid carcinoma, endometriosis and benign endometrium were subjected to an in-depth liquid chromatography-tandem mass spectrometry analysis on the Q-Exactive Plus. Protein identification and quantification were performe...
Source Cite
12345678910